Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.Read More
Filter By Category
In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.Read More
The World Health Organization-approved eLearning tool can be used regardless of Internet access.Read More
Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.Read More
$1 million invested in Institute for the Global Entrepreneur at UC San Diego.Read More
Dominion Harbor and IV to work together to provide greater access to IV portfolio.Read More
As a result of the agreement with IV, Huawei has license to patents related to mobile devices.Read More
New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.Read More
Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.Read More
Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.Read More
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.Read More
The Seattle Times
IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.Read More
CEO of IV spinout Evolv recently joined the DealMakers Podcast to discuss his background and provide some insights for aspiring entrepreneurs.Read More
IV spinout TerraPower continues to develop innovative nuclear energy technology, making it safer, more efficient, and cheaper.Read More
CBS Sunday Morning
Our founder and CEO Nathan Myhrvold shares his experience with high speed food photography and other culinary pursuits with David Pogue.Read More